FCGR2A and neoplasm: Tumor-specific antibodies (mainly IgG1 antibody class), secreted by plasma cells, can bind to FcγR and trigger the complement cascade, mediate the phagocytosis of tumor cells, the cytotoxicity of NK cells, and enhance antigen presentation by DCs [88,89].